ClinConnect ClinConnect Logo
Search / Trial NCT06301009

The AI-CAC Model for Subclinical Atherosclerosis Detection on Chest X-ray

Launched by A.O.U. CITTÀ DELLA SALUTE E DELLA SCIENZA · Mar 3, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Coronary Artery Calcium Chest X Ray Atherosclerotic Cardiovascular Disease Primary Prevention Risk Prediction Artificial Intelligence

ClinConnect Summary

This clinical trial is studying a new artificial intelligence system called the AI-CAC model, which helps detect early signs of a condition known as atherosclerosis using a standard chest X-ray. Atherosclerosis is a problem where the arteries can become narrowed or blocked, leading to heart issues. The goal of the study is to see how well this AI system works in identifying people who may need further testing for coronary artery calcification (CAC), which is a buildup of calcium in the arteries that can indicate heart disease.

To participate in the trial, you need to be between 40 and 75 years old and have a recommendation from your doctor for a chest CT scan to check your CAC score. Unfortunately, if you have had any major heart issues in the past, certain types of cancer, or other serious chronic diseases, you won't be eligible. If you join the study, you'll undergo a chest CT scan, and the researchers will evaluate how accurately the AI system can find signs of atherosclerosis in your results. It's an important step toward improving heart disease prevention and detection.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consent to participate in the study
  • Age between 40 and 75 years
  • Clinical indication from the treating physician to undergo chest CT for CAC score evaluation
  • Exclusion Criteria:
  • Prior cardiovascular events (myocardial infarction, coronary revascularization, transient ischemic attack, stroke, symptomatic peripheral vascular disease, arterial revascularization of peripheral districts)
  • Cancer or other chronic diseases with an estimated prognosis of less than five years
  • Technical contraindications to the execution of chest CT with electrocardiographic gating (highly penetrant atrial fibrillation, frequent ventricular extrasystoles)

About A.O.U. Città Della Salute E Della Scienza

A.O.U. Città della Salute e della Scienza is a leading healthcare institution based in Turin, Italy, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, it integrates cutting-edge research with clinical practice, fostering collaboration among multidisciplinary teams to address complex health challenges. The institution is committed to enhancing therapeutic options and outcomes for patients by conducting rigorous and ethically sound clinical studies that adhere to the highest standards of scientific integrity.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported